First Time Loading...

Chinook Therapeutics Inc
NASDAQ:KDNY

Watchlist Manager
Chinook Therapeutics Inc Logo
Chinook Therapeutics Inc
NASDAQ:KDNY
Watchlist
Price: 40.39 USD Market Closed
Updated: May 9, 2024

Chinook Therapeutics Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chinook Therapeutics Inc
Cash from Operating Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Chinook Therapeutics Inc
NASDAQ:KDNY
Cash from Operating Activities
-$174m
CAGR 3-Years
-38%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Cash from Operating Activities
$22.8B
CAGR 3-Years
9%
CAGR 5-Years
11%
CAGR 10-Years
14%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Operating Activities
$8B
CAGR 3-Years
-5%
CAGR 5-Years
1%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Cash from Operating Activities
$8.1B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
2%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Operating Activities
$3.5B
CAGR 3-Years
3%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Operating Activities
$4.7B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
24%

See Also

What is Chinook Therapeutics Inc's Cash from Operating Activities?
Cash from Operating Activities
-174m USD

Based on the financial report for Jun 30, 2023, Chinook Therapeutics Inc's Cash from Operating Activities amounts to -174m USD.

What is Chinook Therapeutics Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-14%

Over the last year, the Cash from Operating Activities growth was -70%. The average annual Cash from Operating Activities growth rates for Chinook Therapeutics Inc have been -38% over the past three years , -14% over the past five years .